Article Information
History
- October 27, 2022.
Article Versions
- Version 1 (October 22, 2021 - 09:23).
- Version 2 (November 3, 2021 - 10:49).
- Version 3 (November 5, 2021 - 09:01).
- Version 4 (November 6, 2021 - 09:07).
- Version 5 (November 9, 2021 - 10:56).
- Version 6 (January 26, 2022 - 08:54).
- Version 7 (January 28, 2022 - 11:32).
- You are viewing Version 8, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Melina A. Markkanena,b,#,
- Kaisa Haukkaa,g,
- Katariina M. M. Pärnänena,
- Victorien Tamegnon Dougnonc,
- Isidore Juste O. Bonkoungoud,
- Zakaria Garbae,
- Halidou Tintoe,
- Anniina Sarekoskia,
- Antti Karkmana,b,
- Anu Kanteleb,f,g,* and
- Marko P. J. Virtaa,b,#,*
- aDepartment of Microbiology, University of Helsinki, Finland
- bMultidisciplinary Center of Excellence in Antimicrobial Resistance Research, Finland
- cResearch Unit in Applied Microbiology and Pharmacology of Natural Substances, Polytechnic School of Abomey-Calavi, University of Abomey-Calavi, Benin
- dDepartment of Biochemistry and Microbiology, University Joseph KI-ZERBO, Ouagadougou, Burkina Faso
- eClinical Research Unit Nanoro, Institute for Research in Health Sciences, National Center for Scientific and Technological Research, Burkina Faso
- fMeilahti Infectious Diseases and Vaccine Research Center, MeiVac, Department of Infectious Diseases, University of Helsinki and Helsinki University Hospital, Helsinki, Finland
- gHuman Microbiome Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland
- ↵#Corresponding authors: Marko P. J. Virta, marko.virta{at}helsinki.fi, Melina A. Markkanen, melina.markkanen{at}helsinki.fi
↵* Marko P. J. Virta and Anu Kantele contributed equally to this work.